Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Many can't get them due to high costs or lack of insurance
Recent FDA actions, shortage-related policy changes, and ongoing discussions regarding compounded versions of commercially manufactured GLP-1 medications have created new compliance considerations for clinics
Patients who struggled with obesity for decades are seeing sustainable results for the first time
Patients commonly experience gastrointestinal side effects including nausea, vomiting, diarrhea, and constipation, which may further compromise nutritional status
Ozempics manufacturer (Novo Nordisk) also offers patient assistance programs and savings cards that can reduce the drugs out-of-pocket cost
It is important to note that Mounjaro is not licensed for type 1 diabetes or diabetic ketoacidosis
US$ 25.08
US$ 23.28
US$ 21.57
US$ 22.49
